Virtu Financial LLC Kezar Life Sciences, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.6 - $0.92 $7,899 - $12,112	13,166 Added 58.54%	35,657 $21,000
Q1 2024 May 20, 2024	BUY	$0.8 - $1.05 $17,992 - $23,615	22,491 New	22,491 $20,000
Q3 2022 Nov 07, 2022	BUY	$7.99 - $10.75 $96,439 - $129,752	12,070 New	12,070 $104,000
Q2 2022 Aug 09, 2022	SELL	$4.58 - $17.13 $91,654 - $342,805	-20,012 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$12.3 - $18.33 $246,147 - $366,819	20,012 New	20,012 $333,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.